LGALS9 and cancer: Moreover, Gal-9 treatment triggered prominent activation of neutrophils that, in mixed cultures with cancer cells, combined to strongly increase trogocytosis, inhibit cancer cell adhesion, and induce neutrophil-mediated cancer cell death.